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ABSTRACT 
 
Structural microvascular alterations and dysfunction serve as key disease indicators of cancer, 
diabetes, ischemic stroke, neurodegenerative disorders and many other conditions. In vivo 
visualization of the microvasculature has traditionally been restricted to millimeter scale depths 
accessible with optical microscopy. Optoacoustic imaging has enabled breaking through the barrier 
imposed by light diffusion to map functional hemodynamic parameters in deep-seated vessels, but 
diffraction and dispersion of ultrasound waves in heterogeneous living tissues prevents reaching 
capillary resolution. Herein, we demonstrate three-dimensional microangiography of deep mouse 
brain beyond the acoustic diffraction limit (<20 µm resolution) through the intact scalp and skull via 
optoacoustic localization of sparsely-distributed highly absorbing microparticles. This was enabled by 
devising 5 µm sized extremely absorbing dichloromethane microdroplets exhibiting four orders of 
magnitude higher optical absorption than red blood cells at near-infrared wavelengths, thus facilitating 
in vivo compatibility and single particle sensitivity in the presence of highly absorbing blood 
background. Accurate mapping of the blood flow velocity within microvascular structures was also 
facilitated by the high 3D frame rate of the optoacoustic tomography system. We further show that 
the detected optoacoustic signal intensities from the localized particles may serve for estimating the 
light fluence distribution within optically heterogeneous tissues, a long-standing quantification 
challenge in biomedical optics. Given the intrinsic sensitivity of optoacoustics to various functional, 
metabolic and molecular events in living tissues, this new approach paves the way for non-invasive 
deep-tissue microscopic observations with unrivaled resolution, contrast and speed. 
 
Introduction 
 
New methods enabling breaking through established resolution barriers have massively impacted life 
sciences ever since first optical microscopes have overcome the resolution limits of a naked eye 1. 
Optical microscopy performance was subsequently enhanced to reach the light diffraction barrier at 
imaging depths not affected by photon diffusion - typically <1 mm within animal models 2,3. Higher 
resolution has been achieved with electron microscopy 4, while a myriad of technologies based on x-
rays, ultrasound (US) or nuclear magnetic resonance have been developed for deep tissue imaging 5. 
Yet, the unique ability of optical methods to sense specific molecules in vivo often makes them the 
preferred choice for biological observations. Recent efforts have thus been directed toward 
overcoming light diffraction barriers in fluorescence microscopy 6 and developing new optical imaging 
approaches operating at mesoscopic and macroscopic depths 7,8. 
Optoacoustic (OA, photoacoustic) imaging has further emerged as a hybrid modality synergistically 
combining optical contrast and US resolution to provide otherwise unavailable functional and 
molecular information from deep tissues 9,10. A number of advanced OA embodiments enabled 
breaking through the light penetration barrier and attained high spatial resolution (depth-to-resolution 
ratio of ~200) at millimeter to centimeter scale depths 11,12, while further providing unprecedented 3D 
imaging speeds in the kilohertz range 13. These unique features facilitate the interrogation of biological 
samples with very versatile optical-absorption-based contrast, as well as spatial and temporal scales 
not accessible by other modalities. OA microvascular imaging is yet restricted to shallow regions e.g. 
superficial cortical layers 14, while individual capillaries can only be visualized up to a depth of ~1 mm, 
where light can be efficiently focused 15,16. Much like for pulse-echo US, the resolution of OA imaging 
in the light diffusion regime is affected by frequency-dependent acoustic attenuation, which effectively 
reduces the bandwidth of the collected signals and establishes a depth-dependent acoustic diffraction 
limit. Recently, ultrafast US broke through this barrier via localization of single circulating 
microbubbles17. Accurate particle localization is however hampered by acoustic distortions produced 
when pressure waves propagate through strongly mismatched tissues such as the skull bone in brain 
imaging applications. In this regard, OA has an advantage over pulse-echo US as it only involves 
unidirectional propagation of waves generated by light absorption within the sample. We previously 
demonstrated the basic feasibility of localization OA tomography (LOT) by visualizing the flow of 
absorbing microspheres in scattering phantoms 18. LOT was shown to significantly improve the spatial 
resolution of OA tomography (OAT) and microscopy 18-20, while further enhancing the visibility of 
structures under limited-view tomographic conditions. a major deficiency of most OA systems 21. 
Combined with particle tracking, LOT can additionally provide dynamic information on the blood flow, 
namely blood velocity, currently unattainable with OAT. In vivo LOT is however hampered by the strong 
background absorption of blood. Red blood cells (RBCs) consist of ~270·106 hemoglobin molecules 
densely distributed in blood (~50% v/v), while typical OA contrast agents, e.g. based on small 
molecules or nanoparticles, have significantly lower absorbance on a per-unit basis 22. Individual liquid 
droplets and circulating tumor cells could be localized in the mouse brain after intracardiac injection, 
but such large (~30 m diameter) bodies are likely to be arrested in the capillary network 23,24, thus 
hindering in vivo compatibility. Also important is the fact that vascular structures arbitrarily oriented 
in all three dimensions at different depths cannot be efficiently captured with cross-sectional (two-
dimensional, 2D) OAT systems, thus three-dimensional (3D) tomographic imaging turns essential for 
an optimal LOT performance. 
Herein, we demonstrate noninvasive 3D OA localization microangiography in the deep mouse brain by 
means of intravenous (i.v.) bolus injection of extremely absorbing dichloromethane (DCM) 
microdroplets with sizes in the order of RBCs. The small size of the droplets prevents capillary blockage, 
while their strong absorption facilitates individual detection and accurate localization within the field 
of view (FOV) of a volumetric OAT system with a single shot excitation. 
 
Results 
 
The basic principle of LOT along with a lay-out of the tomographic approach used to image the mouse 
brain is depicted in Fig. 1a. A short-pulsed (nanosecond duration) laser tuned to an optical wavelength 
of 780 nm was used to simultaneously illuminate the entire brain and generate pressure (US) waves 
via thermal expansion that are eventually detected with a spherical array of transducers (see methods 
for a detailed description). These pressure waves are produced by endogenous absorbers, mainly 
hemoglobin in RBC, as well as by the exogenously administered absorbing microdroplets required for 
LOT. This leads to a static background OA signal corresponding to vascular structures of different sizes 
superimposed onto a dynamically changing signal generated at the particles flowing in blood. LOT can 
only be performed if the signal generated by an individual (isolated) particle is sufficiently high to be 
detected in a single image voxel. The background signal per voxel is proportional to the number of 
RBCs enclosed, which can reach 100s to 1000s for the given 100 µm resolution of the imaging system. 
The DCM droplets employed have an approximate concentration of ~200 mM of IR-780 dye (extinction 
coefficient ~250·103 M-1cm-1). As a reference, the extinction coefficient of hemoglobin at 780 nm and 
concentration in RBC are ~103 M-1cm-1 and ~5 mM, i.e., the total light absorption in the DCM droplet is 
~104 times higher than in a RBC. The average diameter of the droplets (Fig. 1b, 5.5 m) is smaller than 
the disk diameter of murine RBCs (4-7 m) 25. Individual droplets could clearly be detected in the OA 
images after clutter removal with singular value decomposition (SVD) filtering (see methods for a 
detailed description). Co-registration of OA images with the Allen mouse brain atlas 26 (Fig. 1c) further 
served as anatomical reference to identify the droplets’ position at a given time point. For example, 
three microdroplets in the anterior cerebral artery system (M1, azygos pericallosal artery and M2, 
middle internal frontal artery penetrating branches) and in the pial surface (M3) are clearly visible in 
Fig. 1c. A continuous flow of particles was observed over the entire image sequence, indicating that no 
capillary arrest was induced. Note that the OAT system’s ability to cover an entire 3D region with single 
shot excitation is of particular importance for an accurate trajectory estimation, e.g. when a droplet 
flows from a deep-seated artery to the superficial cortical vasculature (Fig. 1d). In addition, the high 
temporal resolution is paramount for accurately quantifying the relatively high blood flow velocity. 
LOT images were subsequently rendered by aggregating the localized positions of the microdroplets 
flowing through the vascular network over a temporal sequence of OA images (see methods for 
details). No average or compounding of OA frames was required for localizing individual particles. This 
is extremely important considering the high blood flow velocity in the mouse brain (ca. 200 
ml/100g/min, depending on anesthesia and depth from the surface 27,28). The effective integration time 
of the images used for particle localization must be minimized. OA images acquired with a single laser 
pulse (single shot excitation) are very well defined in time by the pulse duration, which facilitates 
accurate localization of particles moving with high velocity. The enhanced resolution achieved with 
LOT with respect to standard (acoustic resolution) OAT is clearly observed e.g. in the dorsal view of the 
mouse brain vasculature (Figs. 2a,b). Pial arterioles such as the anterior cerebral artery, the middle 
cerebral artery and the posterior cerebral artery, as well as the superior sagittal sinus are clearly 
identified in the LOT image. Pial arterioles and penetrating arterioles (long and short cortical branches) 
across the cortex over the expected thickness (~1 mm) 14,29 are also clearly visible (approx. Bregma -
0.22 mm to -1.22 mm, Fig. 2b coronal view). Such features cannot be resolved in standard OAT images 
not only because of its inferior resolution but chiefly due to limited-view effects hindering 
reconstruction of vertically-oriented structures 21. Vascular structures separated by 22 m could be 
resolved over a depth range of ~1.5 mm from the brain cortex (~2.5 mm from the skin surface) through 
the intact scalp (estimated thickness 0.5 mm) and skull (estimated thickness 0.4-0.6 mm) 30,31. Note 
that the spatial resolution in LOT depends on the number of droplets passing through each 
reconstructed voxel (10x10x10 m3) and thus could potentially be improved by using a longer 
acquisition time or a higher droplet concentration – approximately 20 droplets were localized in each 
volumetric frame in the present case.  
The high temporal resolution of the 3D OAT imaging system further enabled estimating the blood flow 
velocity via particle tracking (see methods section for a detailed description). The reconstructed 
velocity map (Fig. 2d) is consistent with previously reported values for the mouse brain, i.e. from 
several cm/s in major cerebral arteries - typical blood flow range is 0.5-1.6 ml/g/min depending on the 
brain region and depth 32,33 - down to below 5 mm/s in smaller vessels 34,35. It was further possible to 
accurately assess the velocity profile across relatively large vessels, revealing a Poiseuille-like flow 
profile (inlet in Fig. 2d). The capability to accurately quantify the blood flow represents an important 
new feature in the unique functional imaging portfolio of OAT, which is already capable of measuring 
various hemodynamic parameters such as blood volume and oxygen saturation 36,37. Finally, it is 
important to take into account that the OA signal generated by the microdroplets is directly 
proportional to the local light fluence. We observed a clear signal decay with depth (Fig. 2e, top, 
approx. Bregma -1.46 mm). The light fluence distribution could then be estimated by fitting an 
exponentially decaying function to the measured signal intensities at different positions in this section 
(Fig. 2e bottom, see methods for a detailed description). As the tissue composition is different in 
white/gray matter and across brain regions, a heterogeneous fluence distribution is generally 
expected. Brain atlas co-registration was further facilitated by identifying vessels in the coronal 
section, e.g. the pial artery, transverse hippocampal artery/vein and middle cerebral artery, thus 
accurately assessing which brain regions are efficiently illuminated (Fig. 2e bottom). 
 
Discussion 
 
The ability to localize and track intravenously injected micron-size particles in 3D and in the presence 
of highly absorbing blood background empowers LOT with an unprecedented capacity for microscopic 
in vivo imaging of deep optically opaque tissues. Breaking through the acoustic diffraction barrier 
facilitates volumetric visualization of microvascular structures not captured in standard OAT images. It 
was shown that LOT can achieve 20 m resolution across >3 mm depth range through an intact scalp 
and skull. Apart from its superb spatial resolution and better visibility of structures under limited-view 
tomographic conditions, LOT enables quantification of the local light fluence and blood flow velocity. 
Key to these enabling features are the high 3D imaging frame rate (100 Hz), short duration of the 
excitation laser pulse (<10 ns) and sufficient detection sensitivity for capturing entire 3D image 
volumes with single-shot excitation.  
The use of strong micron-size absorbers is an important pre-requisite for successful in vivo application 
of the LOT technique as they effectively break the continuity in the absorption distribution induced by 
densely-packed RBCs and can easily be localized, even without employing broad angular coverage for 
OAT image acquisition. Indeed, LOT is capable of rendering accurate vascular images under limited-
view conditions, thus overcoming another major limitation of the commonly employed OAT systems 
21. Limited-view effects are associated with the speckle-free nature of OAT and have been commonly 
averted by artificially inducing speckle grains in the images 38-40, which is equally possible in LOT even 
if the injected particles cannot be individually distinguished. The ability of LOT to directly measure light 
fluence distribution in deep tissues and anatomical co-registration based on atlas delineation of 
white/gray matter structures, addresses another important long-standing challenge in biomedical 
optics 41. Particularly, OA image normalization with fluence is essential for achieving accurate readings 
of the concentration of agents or rendering physiologically-relevant blood oxygenation measurements 
in the presence of spectral coloring effects in deep tissues 42,43. Fluence estimation may further be 
facilitated with monodisperse droplets, which can potentially be synthetized with microfluidic chips. 
The microdroplets employed in this work have a similar size to food and drug administration (FDA)-
approved microbubbles used as US contrast agents. The demonstrated results may thus foster clinical 
translation of OA imaging. On the other hand, the FDA-approved indocyanine green (ICG) agent has a 
similar extinction coefficient as the IR780 dye used in our study, making it an ideal candidate for 
undergoing the regulatory approval process once properly encapsulated into a microparticulate agent. 
Beyond their relevance for LOT, strongly absorbing microparticles smaller than RBCs may emerge as 
powerful agents for enhancing OA contrast significantly outperforming the existing OA contrast agents 
based on small molecule dyes and nanoparticles.  
LOT can greatly impact our understanding of brain microvascular organization and function and 
provide new insights into major research challenges in neuroscience 44. It can enhance the capabilities 
of OAT to provide hemodynamic readings e.g. of oxygen saturation or cerebral blood volume by 
additionally enabling quantifying cerebral blood flow or diameter changes in microvascular structures. 
LOT may then emerge as a unique tool for studying neurovascular coupling and stimulus responses 
e.g. in subcortical regions not accessible with other modalities 45. Cerebrovascular structural 
alterations and dysfunction play critical roles and are key disease biomarkers in multiple diseases such 
as hypertension, ischemic stroke, brain cancer, traumatic brain injury or Alzheimer’s and tauopathy 
diseases 46-48. Magnetic resonance imaging (MRI) and x-ray computed tomography (CT) have been used 
to detect vessel remodeling, blood flow disturbances and vascular density in humans and in murine 
disease models with suboptimal resolution 49. Two-photon microscopy and laser speckle imaging have 
alternatively been used to map the microvascular blood flow, but are only applicable at shallow depths 
(<1 mm from the accessible surface) 27,32,50. The ability of LOT to visualize blood flow dynamics in the 
middle and anterior cerebral arteries (both pial and penetrating arterioles) enables e.g. studying the 
mechanisms of reperfusion after middle cerebral artery occlusion 51, monitoring treatments for 
neuroprotection neuroplasticity after stroke or characterizing intracerebral hemorrhages after 
immunotherapy 52.  
Taken together, these unique enabling features can massively impact our understanding on the 
structural and functional properties of cerebral microvasculature under physiological and diseased 
conditions. In a broader perspective, LOT can be used to facilitate early diagnosis based on bio-markers 
associated with microcirculatory alterations in diabetes, cancer, cardiovascular disorders, ischemic 
stroke or neurodegenerative diseases, while additionally providing new insights into disease 
progression, efficacy of drugs and other therapeutic interventions. In conclusion, the newly developed 
capacity for rapid volumetric mapping and characterization of microvascular structures in vivo with 
spatial resolution beyond the acoustic diffraction barrier is poised to provide unprecedented insights 
into the anatomy and function of optically opaque organisms. We anticipate that the advantages 
provided by LOT, combined with the unique features of state-of-the-art OAT, will massively impact a 
large number of studies on clinically relevant diseases and further foster the growing use of OA as a 
biomedical imaging tool. 
 
Methods 
 
Microdroplet synthesis and characterization 
A suspension of dichloromethane (DCM, Sigma Aldrich, 270997) microdroplets in water was produced 
following a standard emulsification procedure. The disperse (DCM) phase was prepared by diluting 
30 g of IR-780 iodide (Sigma-Aldrich, 425311) in 200 ml of DCM to achieve a dye concentration of 
approximately 200 mM. The continuous (water) phase was prepared by adding 3% (v/v) Tween 20 
surfactant (Sigma Aldrich, P1379) in phosphate buffered saline (PBS, Sigma Aldrich, 79378). 50 l of 
disperse phase and 1.5 ml of continuous phase were mixed in a 2 ml Eppendorf and vortexed at speed 
9 during 30 s. The continuous phase was cooled down to approximately 4°C before vortexing to avoid 
vaporization of DCM. The resulting emulsion was eventually filtered with a cell strainer with pore size 
10 m (PluriStrainer 10 m, pluriSelect Life Science, Leipzig, Germany) and subsequently inspected in 
a stereo microscope (Carl Zeiss AG, Oberkochen , Germany) to verify that no particles with irregular 
(non-spherical) shape, arguably corresponding to the dye powder, are present in the suspension. The 
diameters of the droplets obtained after filtering the suspension with the cell strainer with pore size 
10 m were measured in the images taken with a bright field microscope (Leica Camera AG, Wetzlar, 
Germany, 5X objective). Specifically, a total of 500 circles were automatically detected and 
characterized (MATLAB function imfindcircles) and the results were displayed as histograms (Fig. 1b). 
Optoacoustic imaging system 
OA imaging of the mouse brain was performed with a tomographic imaging system schematically 
illustrated in Fig. 1a. A spherical array of 512 US sensing elements (Imasonic SaS, Voray, France) was 
used to collect the corresponding OA signals generated via excitation with an optical parametric 
oscillator (OPO)-based short-pulsed (<10 ns) laser (Innolas GmbH, Krailling, Germany) tuned to 
780 nm, corresponding to the peak absorption of the dye. The elements of the US array have 7 MHz 
central frequency and >80% detection bandwidth. The array features a central aperture with 8 mm 
diameter and 3 lateral apertures with 4 mm diameter located at 45° elevation angle and equally spaced 
(120°) in the azimuthal direction. Light was guided with a custom-made 4-arm fiber bundle 
(CeramOptec GmbH, Bonn, Germany) through the apertures of the array. This provided an 
approximately uniform illumination profile on the mouse brain surface with optical fluence 
<20 mJ/cm2. The OA signals were digitized at 40 megasamples per second with a custom-made data 
acquisition system (DAQ, Falkenstein Mikrosysteme GmbH, Taufkirchen, Germany) triggered with the 
Q-switch output of the laser and transmitted to a computer via Ethernet. 
Animal model 
Female athymic nude mice (n=5, 6-8 weeks old, Janvier Lab, France) were used for in vivo experiments. 
Animals were housed in ventilated cages inside a temperature-controlled room under a 12-hour 
dark/light cycle. Pelleted food and water were provided ad-libitum. All experiments were performed 
in accordance with the Swiss Federal Act on Animal Protection and were approved by the Cantonal 
Veterinary Office Zürich (ZH 161/18). 
In vivo LOT imaging  
Mice were anaesthetized with isoflurane (4% v/v for induction and 1.5% during the experiments, 
Abbott, Cham, Switzerland) in an oxygen/air mixture (100/400 mL/min). OA imaging of the brain region 
was performed with the head of the mouse fixed into a custom-designed stereotactic mouse head 
holder coupled to a breathing mask (Narishige International, Japan). Blood oxygen saturation, heart 
rate and body temperature were continuously monitored (PhysioSuite, Kent Scientific) and the 
temperature was maintained at ~36°C with a heating pad. Bolus injection (i.v.) of 100 ml of the 
microdroplet emulsion was performed 30 s after the beginning of data acquisition, where the total 
acquisition time was 420 s. Four mice were euthanized under deep anesthesia (5% isoflurane for 5 
minutes) and subsequently decapitated without waking them up. To examine the possible toxicity of 
the microdroplet emulsion, the health condition and behavior of one mouse was monitored (3 
times/day) for 24 hours after the in vivo imaging. The mouse was subsequently euthanized as 
described above. The mouse fully recovered and no effect on the well-being and behavior was 
observed.  
Image reconstruction 
OA images for a volume of 10x10x5 mm3 (100x100x50 voxels) were reconstructed with a graphics 
processing unit (GPU)-based implementation of a back-projection formula 53. Prior to reconstruction, 
the collected signals were band-pass filtered with cut-off frequencies 0.1 and 9 MHz. A singular value 
decomposition (SVD) clutter filter was further applied to the raw OA signal data to reconstruct the OA 
images used for single droplet localization 54. This enabled isolating the signal fluctuations ascribed to 
absorbing particles flowing in the vasculature from the static (backgroung) signal coming from 
endogenous absorbers such as hemoglobin (20 singular vectors out of 500 were removed). A reference 
OA image was also reconstructed after applying the same filter for comparison purposes (Fig. 2a). 
Image registration 
Registration between OA images and Allen mouse brain atlas was performed to further provide a 
better anatomical reference for identifying cerebral vascular structures. Specifically, an annotated 
Allen brain atlas 26 was used to identify brain regions in the OAT and LOT datasets. The reference atlas 
was manually aligned with the OA images (Amira) and for annotation of the vessels 55, which provided 
the best contrast for distinguishing the cerebral vasculature. 
Droplets localization and tracking 
Isolated microdroplets are strong absorbers smaller in size than the resolution of our imaging system 
and thus appear in the image as the local point spread function (PSF). In each reconstructed frame, 
local intensity maxima were detected, and small regions around these maxima were correlated to a 
model PSF of our imaging system (note that the same empirical PSF was used over the whole 
reconstructed volume). The maxima with correlation coefficients above 0.5 were considered as 
droplets. Localization of these droplets was then further refined using a local quadratic fitting of the 
intensity maxima, and their positions were stored. A particle tracking algorithm was then used on these 
positions (simpletracker.m available on mathworks ©Jean-Yves Tinevez, 2019, wrapping matlab 
munkres algorithm implementation of ©Yi Cao 2009) in order to track the droplets over consecutive 
frames. A maximal linking distance of 0.5 mm was selected, which corresponds to a maximum particle 
velocity of 50 mm.s-1. 
Fluence estimation 
The amplitude of the OA signal generated by a droplet is proportional to the amount of energy 
absorbed times the local flight fluence. The absorbed energy depends on the volume of the droplet, 
which changes according to the size distribution. However, given the narrow distribution of the droplet 
size, the light fluence can be assumed to be proportional to the average intensity of the OA signals 
reconstructed for droplets at a given location. For fluence estimation, 50 droplets were selected in a 
cross-sectional image of the brain. The intensities of the differential OA images for the positions of the 
selected droplets were fitted to an exponentially decaying function. Specifically, a function of the form 
(a/z)exp(-bz) was used for least square fitting, being z=sqrt((x-x0)^2+(y-y0)^2)). Curve fitting resulted 
in optimum values of the parameters a, b, x0 and y0. 
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 Figure 1. Detection and tracking of individual microdroplets with 3D optoacoustic (OA) tomography. 
(a) Lay-out of the suggested approach. AM – absorbing microdroplets, LB – laser beam, UW – 
ultrasound waves, SA – spherical array. (b) Bright field (5X) optical microscopy image of the 
dichloromethane (DCM) microdroplets along with a histogram of the measured diameters (500). 
Scalebar – 50 m. (c) OA images of the mouse brain superimposed to the differential (background 
substracted) OA (OA) images. Three microdroplets in the azygos pericallosal artery (M1), middle 
internal frontal artery penetrating branches (M2) and pial surface (M3) are labelled in the differential 
image. The co-registered Allen mouse brain atlas is also shown. ACA – anterior cerebral artery. Scalebar 
– 3 mm. (d) Maximum intensity projections (MIPs) of the differential OA image along the z and x 
directions for the rectangular box indicated in (c). Three representative time points are shown. The 
depth from the pia matter (PM) and the calculated velocities are indicated in blue and yellow, 
respectively. Scalebar – 1 mm. 
 
  
 Figure 2. Optoacoustic (OA), blood flow and light fluence images. (a) Maximum intensity projections 
(MIPs) along the z direction (dorsal view) of the 3D images rendered with standard OA tomography 
(OAT, left) and localization optoacoustic tomography (LOT, right). ACA – anterior cerebral artery, MCA 
– middle cerebral artery, PCA – posterior cerebral artery, SSS – superior sagittal sinus. Scalebar – 3 mm. 
(b) MIP along the x direction (coronal view, Bregma -0.22mm to -1.22 mm) of the rectangular box of 
the LOT image indicated in (a). Cortical layers are indicated. The inlet displays a 3D view of the indicated 
region. PA – pial arteriole, PB – penetrating branches. Scalebar – 1 mm. (c) Profile of the LOT image for 
the dashed white line in (b). (d) 3D view of the blood flow image. Inlet shows boxplots of the measured 
velocities along the dashed black line. Statistical significance is shown. Scalebar - 3 mm. (e) Cross-
sectional coronal view (top, approx. Bregma -1.46 mm) of the OA image along with the superposition 
of 8 differential OA images (OA). The light fluence image (bottom) is derived by fitting the signals of 
50 microdroplets in the differential OA images to an exponentially decaying function. MCA – middle 
cerebral artery, PA – pial artery, THV – transverse hippocampal vein, CTX – cortex, CC – corpus 
callosum, HIP – hippocampus, TH – thalamus, ST – striatum, AM – amygdala. Scalebar – 5 mm. 
 
